688617 logo

APT Medical Inc. Stock Price

SHSE:688617 Community·CN¥29.6b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

688617 Share Price Performance

CN¥0
-298.00 (-100.00%)
CN¥0
-298.00 (-100.00%)
Price CN¥0

688617 Community Narratives

There are no narratives available yet.

Trending Discussion

No trending discussion available.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Very undervalued with flawless balance sheet.

1 Risk
4 Rewards

APT Medical Inc. Key Details

CN¥2.7b

Revenue

CN¥749.7m

Cost of Revenue

CN¥2.0b

Gross Profit

CN¥1.1b

Other Expenses

CN¥866.9m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Aug 20, 2026
6.14
72.48%
31.83%
0.3%
View Full Analysis

About 688617

Founded
2002
Employees
3118
CEO
Zhenghui Cheng
WebsiteView website
www.aptmed.com

APT Medical Inc. engages in the research and development, production, and sale of cardiovascular interventional medical devices in China. It offers electrophysiology products, such as navigation systems, navigated catheters, mapping catheters, ablation catheters, transseptal needles and sheaths, and steerable sheaths; and interventional cardiology and peripheral products, including access, diagnostic products, therapeutic products, and accessories. The company also manufactures and supplies EP and vascular intervention medical devices. In addition, it provides OEM and ODM services comprising project design and development, customization, and volume OEM; and customized products consisting of catheters, guidewires, and delivery systems, as well as nitinol products in cardiology, peripheral, neurology, and urology. APT Medical Inc. was founded in 2002 and is headquartered in Shenzhen, China.

Recent 688617 News & Updates

Recent updates

No updates